MARCO and neoplasm: The downregulation of the macrophage receptor MARCO following HKMTI-1–005 treatment is also an intriguing finding; inhibiting MARCO reprogrammes macrophages to acquire an antitumor phenotype, inhibiting tumor cell growth (52).